You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial
|
|---|---|
| Published in |
BMC Cancer, April 2009
|
| DOI | 10.1186/1471-2407-9-120 |
| Pubmed ID | |
| Authors |
Erik Skof, Martina Rebersek, Zvezdana Hlebanja, Janja Ocvirk |
Mendeley readers
The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 66 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 10 | 15% |
| Researcher | 10 | 15% |
| Other | 7 | 11% |
| Student > Master | 4 | 6% |
| Student > Bachelor | 3 | 5% |
| Other | 12 | 18% |
| Unknown | 20 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 45% |
| Psychology | 3 | 5% |
| Nursing and Health Professions | 2 | 3% |
| Arts and Humanities | 2 | 3% |
| Engineering | 2 | 3% |
| Other | 7 | 11% |
| Unknown | 20 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2023.
All research outputs
#5,559,757
of 25,837,817 outputs
Outputs from BMC Cancer
#1,474
of 9,083 outputs
Outputs of similar age
#21,606
of 109,172 outputs
Outputs of similar age from BMC Cancer
#7
of 35 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,083 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,172 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.